European Archives - Page 240 of 1125 - European Medical Journal

FDA lifts partial clinical hold on Rezolute hyperinsulinism treatment

The lift is based on new research showing that the previous adverse effects in laboratory rats may not have been caused by the drug itself.

New AI-focused RNA collaboration for Eli Lilly

Eli Lilly has entered into a research collaboration with Genetic Leap, a private company focused on AI, to advance the development of RNA-based genetic medicines.

Driving change within the PFIC landscape

A lot has changed within the Progressive Familial Intrahepatic Cholestasis (PFIC) landscape in the last few years. The introduction of…

Restaging MRI Helps Predict Outcomes in Rectal Cancer Treatment

A new study highlights the crucial role of MRI in predicting key oncologic outcomes, such as organ preservation and survival

Does AI Improve Diagnostic Accuracy of Intracranial Haemorrhage?

A new study has shown that AI assistance did not significantly enhance radiologists’ diagnostic accuracy or reduce report turnaround times.

Vitamin E Improves Liver Health in Patients with MASLD

A new study found that vitamin E supplementation can significantly improve liver health in adults with metabolic dysfunction-associated steatotic liver disease.

New Insights into Effect of Vaping on Fitness: ERS 2024

This research has added to the growing body of evidence about the negative long-term effects of vaping.

Long-Term Air Pollution Exposure Linked to Respiratory Hospitalisations: ERS 2024

Research presented at the European Respiratory Society (ERS) Congress has revealed that prolonged exposure to air pollution increases the risk of hospitalisation for respiratory conditions

AI Detects Pulmonary Embolism Early Using Medical Records

A recent study utilised AI to detect pulmonary embolism early using only patient records.

Brain Tumour Treatment Affects Academic Readiness

A study investigated academic readiness, its predictors, and its relationship with later academic performance in patients treated for CNS tumours during early childhood.